Could a drug initially developed to treat chronic obstructive pulmonary disease (COPD) be useful in treating type 2 diabetes? Allegheny Health Network’s Institute of Cellular Therapeutics has received a $2.2 million grant from the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) to explore that possibility.
(PRWeb December 15, 2015)
Read the full story at http://www.prweb.com/releases/2015/12/prweb13130044.htm
For more information, please visit
http://www.prweb.com/releases/2015/12/prweb13130044.htm